Cargando…

Effect of Combined Dasatinib and Fisetin Treatment on Senescent Cell Clearance in Monkeys

Aging is the biggest risk factor for the most serious chronic diseases and disabilities. Cellular senescence, a state in which cells stop dividing but release factors that damage other cells, may contribute to both age-related and chronic diseases. Removal of senescent cells from aged mice has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colman, Ricki, Tchkonia, Tamara, Pirtskhalava, Tamar, Giorgadze, Nino, Prata, Larissa, Schaefer, Kalli, Kirkland, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740648/ http://dx.doi.org/10.1093/geroni/igaa057.432

Ejemplares similares

New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463
por: Zhu, Yi, et al.
Publicado: (2017)

Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023)

ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
por: Zhu, Yi, et al.
Publicado: (2022)

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
por: Hickson, LaTonya J., et al.
Publicado: (2019)

A chronic wound model to investigate skin cellular senescence
por: Wyles, Saranya P., et al.
Publicado: (2023)

SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3
por: Tripathi, Utkarsh, et al.
Publicado: (2021)

Targeting senescent cells enhances adipogenesis and metabolic function in old age
por: Xu, Ming, et al.
Publicado: (2015)

Fisetin is a senotherapeutic that extends health and lifespan
por: Yousefzadeh, Matthew J., et al.
Publicado: (2018)

Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456
por: Hickson, LaTonya J., et al.
Publicado: (2020)

Cellular Senescence: A Translational Perspective
por: Kirkland, James L., et al.
Publicado: (2017)

Deleted in Breast Cancer 1 regulates cellular senescence during obesity
por: Escande, Carlos, et al.
Publicado: (2014)

Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
por: Ogrodnik, Mikolaj, et al.
Publicado: (2019)

Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
por: Ogrodnik, Mikolaj, et al.
Publicado: (2019)

Targeting cellular senescence in metabolic disease
por: Palmer, Allyson K., et al.
Publicado: (2022)

Growth hormone in adipose dysfunction and senescence
por: Stout, Michael B., et al.
Publicado: (2015)

Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022)

Whole‐body senescent cell clearance alleviates age‐related brain inflammation and cognitive impairment in mice
por: Ogrodnik, Mikolaj, et al.
Publicado: (2021)

Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice
por: Cavalcante, Marcelo B., et al.
Publicado: (2020)

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
por: Nambiar, Anoop, et al.
Publicado: (2023)

Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
por: Zhu, Yi, et al.
Publicado: (2016)

Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice
por: Xu, Ming, et al.
Publicado: (2017)

Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era
por: Verdoorn, Brandon P., et al.
Publicado: (2021)

The Common Marmoset: A Highly Translatable Small Nonhuman Primate Model of Aging
por: Colman, Ricki
Publicado: (2021)

Aging, Depot Origin, and Preadipocyte Gene Expression
por: Cartwright, Mark J., et al.
Publicado: (2010)

COVID-19 and cellular senescence
por: Schmitt, Clemens A., et al.
Publicado: (2022)

Deleted in Breast Cancer 1 Limits Adipose Tissue Fat Accumulation and Plays a Key Role in the Development of Metabolic Syndrome Phenotype
por: Escande, Carlos, et al.
Publicado: (2015)

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
por: Song, Shuling, et al.
Publicado: (2020)

Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies
por: Wyld, Lynda, et al.
Publicado: (2020)

Palmitate induces DNA damage and senescence in human adipocytes in vitro that can be alleviated by oleic acid but not inorganic nitrate
por: Ishaq, Abbas, et al.
Publicado: (2022)

Aged‐senescent cells contribute to impaired heart regeneration
por: Lewis‐McDougall, Fiona C., et al.
Publicado: (2019)

Aging, Senescent Cells, and Senolytic Drugs: The Path to Translation
por: Kirkland, James
Publicado: (2020)

Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment
por: Fang, Yimin, et al.
Publicado: (2023)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

Targeted clearance of p21‐ but not p16‐positive senescent cells prevents radiation‐induced osteoporosis and increased marrow adiposity
por: Chandra, Abhishek, et al.
Publicado: (2022)

Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
por: Suda, Masayoshi, et al.
Publicado: (2023)

Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice
por: Stout, Michael B., et al.
Publicado: (2014)

Targeting cellular senescence prevents age-related bone loss in mice
por: Farr, Joshua N., et al.
Publicado: (2017)

Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep
por: Huard, Charles A., et al.
Publicado: (2023)

CELLULAR SENESCENCE AS A THERAPEUTIC TARGET FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019)

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
por: Zhu, Yi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m0j6c34828avnebaje8dbgo2cm